HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mohamed A Kamal Selected Research
Mohamed A Kamal Research Topics
Disease
10
Atopic Dermatitis (Atopic Eczema)
11/2023 - 01/2020
6
Human Influenza (Influenza)
11/2023 - 02/2013
6
Body Weight (Weight, Body)
11/2023 - 08/2013
5
Infections
11/2023 - 07/2015
5
Eczema
11/2023 - 01/2020
4
Asthma (Bronchial Asthma)
01/2023 - 01/2021
4
Conjunctivitis
01/2022 - 01/2020
3
Inflammation (Inflammations)
01/2023 - 01/2022
3
Hypersensitivity (Allergy)
01/2022 - 11/2021
2
Allergic Rhinitis
12/2022 - 01/2022
2
Chronic Kidney Failure (Chronic Renal Failure)
11/2015 - 04/2015
1
Eosinophilic Esophagitis
12/2022
1
Disease Progression
12/2022
1
Ebola Hemorrhagic Fever
10/2022
1
Hemorrhage
10/2022
1
Seasonal Allergic Rhinitis (Hay Fever)
01/2022
1
Pneumonia (Pneumonitis)
01/2022
1
Blepharitis
01/2021
1
Keratitis
01/2021
1
Injection Site Reaction
01/2020
1
Erythema
07/2015
1
Exanthema (Rash)
07/2015
1
Anuria
04/2015
1
Non-alcoholic Fatty Liver Disease
01/2013
1
Insulin Resistance
01/2013
1
Sleepiness
08/2010
1
Dizziness (Lightheadedness)
08/2010
1
Communicable Diseases (Infectious Diseases)
01/2008
1
Porphyrias (Porphyria)
01/2008
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
09/2004
Drug/Important Bio-Agent (IBA)
13
dupilumab
IBA
11/2023 - 01/2020
9
Monoclonal Antibodies
IBA
12/2022 - 11/2021
8
Oseltamivir (Tamiflu)
FDA Link
11/2023 - 02/2013
4
Immunoglobulin A (IgA)
IBA
11/2023 - 01/2020
4
Allergens
IBA
12/2022 - 11/2021
4
oseltamivir carboxylate
IBA
01/2017 - 06/2015
3
Interleukin-4 (Interleukin 4)
IBA
01/2023 - 01/2022
3
Immunoglobulin G (IgG)
IBA
01/2022 - 11/2021
3
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2022 - 09/2004
2
Interleukin-13
IBA
12/2022 - 01/2022
2
Antiviral Agents (Antivirals)
IBA
10/2022 - 01/2017
2
Antibodies
IBA
01/2022 - 01/2020
2
Albumins
IBA
11/2021 - 01/2020
1
Chemokine CCL17
IBA
11/2023
1
Biomarkers (Surrogate Marker)
IBA
01/2023
1
Vaccines
IBA
12/2022
1
Creatinine
IBA
10/2022
1
Nitrogen
IBA
10/2022
1
atoltivimab, maftivimab, and odesivimab-ebgn drug combination
IBA
10/2022
1
Urea (Carbamide)
FDA Link
Generic
10/2022
1
Alanine (L-Alanine)
FDA Link
10/2022
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
10/2022
1
itepekimab
IBA
01/2022
1
Interleukin-33
IBA
01/2022
1
Interleukin-4 Receptors (Interleukin 4 Receptor)
IBA
01/2022
1
Glycoproteins (Glycoprotein)
IBA
01/2022
1
Combined Antibody Therapeutics
IBA
01/2022
1
Immunoglobulin Isotypes
IBA
01/2022
1
Interleukins
IBA
01/2022
1
ML 23
IBA
07/2015
1
Phosphates (Orthophosphate)
IBA
06/2015
1
Neuraminidase (Sialidase)
IBA
02/2013
1
Nonesterified Fatty Acids (NEFA)
IBA
01/2013
1
Enzymes
IBA
01/2013
1
Triglycerides (Triacylglycerol)
IBA
01/2013
1
Lorazepam (Ativan)
FDA Link
Generic
08/2010
1
Acids
IBA
01/2008
1
Cefadroxil (Duricef)
FDA Link
Generic
01/2008
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2008
1
Peptidomimetics
IBA
01/2008
1
Immunosuppressive Agents (Immunosuppressants)
IBA
09/2004
1
Prednisolone (Predate)
FDA Link
Generic
09/2004
Therapy/Procedure
3
Therapeutics
01/2022 - 09/2004
1
Immunotherapy
01/2022
1
Renal Dialysis (Hemodialysis)
11/2015
1
Continuous Ambulatory Peritoneal Dialysis (CAPD)
04/2015
1
Peritoneal Dialysis
04/2015